HMPV

     HMPV = Human metapneumovirus

Human metapneumovirus (HMPV) is a respiratory virus that primarily affects the upper and lower respiratory tract. Discovered in 2001, it belongs to the Paramyxoviridae family, closely related to the respiratory syncytial virus (RSV). HMPV is a significant cause of respiratory infections, especially in young children, the elderly, and immunocompromised individuals.

Symptoms

HMPV symptoms range from mild to severe and include:

• Fever
• Cough
• Nasal congestion
• Wheezing
• Shortness of breath

Severe cases can lead to bronchitis or pneumonia, particularly in vulnerable groups.

Transmission

The virus spreads through respiratory droplets, close contact with infected individuals, and contaminated surfaces. The incubation period is 3-5 days.

Treatment

Currently, there is no specific antiviral treatment or vaccine for HMPV. Management focuses on supportive care:

• Hydration
• Fever and symptom management
• Oxygen therapy in severe cases

Prevention

• Regular handwashing
• Wearing masks in crowded places
• Avoiding close contact with sick individuals
• Improving ventilation in indoor spaces

HMPV infections tend to peak in late winter and early spring, similar to flu and RSV.